AQP5 and chronic myelogenous leukemia, BCR-ABL1 positive: This expression profile in CML is comparable to that in solid tumors; AQP5 is expressed in 35% (144/408) of non-small-cell lung cancer [19], and similar observations were also found in breast cancer (manuscript in preparation).